GDF2 and Alzheimer disease: Similarly, Burke et al., working on a mouse model of AD (APP.PS1, transgenic mouse overproducing β–amyloid peptides), demonstrated that intraventricular injections of BMP-9 dramatically reduced the accumulation of senile plaques in the cortex and hippocampus, and increased the ChAT levels13.